wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33771405-01BAB6F2-0488-4479-A507-F1FD578D5DBA
Q33771405-01BAB6F2-0488-4479-A507-F1FD578D5DBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33771405-01BAB6F2-0488-4479-A507-F1FD578D5DBA
Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.
P2860
Q33771405-01BAB6F2-0488-4479-A507-F1FD578D5DBA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33771405-01BAB6F2-0488-4479-A507-F1FD578D5DBA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
426b1bc0c7a6d8c69f18cf00b873aef7e8137fe1
P2860
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.